Spots Global Cancer Trial Database for ampullary
Every month we try and update this database with for ampullary cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer | NCT04163900 | Biliary Tract C... | NUC-1031 Gemcitabine Cisplatin | 18 Years - | NuCana plc | |
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers | NCT00660699 | Cholangiocarcin... Gallbladder Can... Pancreatic Canc... Ampullary Cance... | Gemcitabine Docetaxel Radiation | 18 Years - | Washington University School of Medicine | |
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers | NCT00660699 | Cholangiocarcin... Gallbladder Can... Pancreatic Canc... Ampullary Cance... | Gemcitabine Docetaxel Radiation | 18 Years - | Washington University School of Medicine |